Anest. intenziv. Med. 2013;24(3):169-178
N-Terminal-Pro Brain Natriuretic Peptide (NT-pro BNP) and Troponin I as prognostic markers of septic cardiomyopathyIntensive Care Medicine - Original Paper
- 1 Klinik für Anästhesiologie und operative Intensivmedizin, Klinikum Bayreuth GmbH, Deutschland
- 2 KARIM UK v Praze, LF v Hradci Králové a FN Hradec Králové
Objective:
Cardiac dysfunction might be a considerable factor determining the outcome of critically ill patients. NT-pro BNP is highly predictive for the functional and troponin I for the morphological heart dysfunction in septic, critically ill patients. We compared the sensitivity and specificity of NT-pro BNP and troponin I in septic patients to the outcome markers SOFA score and procalcitonin.
Design:
Prospective, observational trial.
Setting:
Surgical Intensive Care Unit (SICU) at a tertiary care hospital.
Materials and Methods:
The trial criteria were met by 16 survivors and 17 non-survivors with severe sepsis or septic shock. ROC curves analysis was made for seven consecutive days of severe sepsis.
Results:
NT-pro BNP was a significantly better prognostic parameter than other parameters (AUC on day 3 = 0.850, cut-off value ≤ 3910 pg/ml) from the third day of severe sepsis. The highest AUC of NT-pro BNP was measured on day 4 (AUC = 0.878) with sensitivity of 100.0% (95% CI 66.4-100.0) and specificity of 80.0% (95% CI 44.4-97.5) by cut-off value ≤ 5 473 pg/ml. Troponin I showed insufficient results in the first two days of severe sepsis with continuous improvement in the next five observed days. The highest AUC was measured on day 4 (AUC = 0.811). The sensitivity of the best cut-off value of troponin I(≤ 0.1 ng/ml) on day 4 was 100.0% (95% CI 66.4-100.0) and specificity 70% (95% CI 34.8-93.3). Procalcitonin was significant at the beginning of severe sepsis only. The best AUC for procalcitonin was measured on day 1 (0.761). SOFA score correlated with the outcome of critically ill septic patients from day 3 and reached the best values on day 6 (AUC = 0.795).
Conclusions:
NT-pro BNP values higher than 3910 pg/mland positive troponin I values in septic patients over 65 years taken on day 3 could be an early marker of risk in patients with myocardial dysfunction. Continuously rising values of NT-pro BNP and higher levels of troponin I during severe sepsis are helpful prognostic markers, superior to other predictors of outcome. Rising values of NT-proBNP and troponin I need diagnostic precision and targeted therapy of septic myocardial dysfunction.
Keywords: natriuretic peptides; cardiac troponins; septic cardiomyopathy; diagnosis; prognosis
Received: July 10, 2012; Accepted: February 20, 2013; Published: June 1, 2013 Show citation
References
- Almog, Y. et al. Plasma level of N terminal pro-brain natriuretic peptide as a prognostic marker in critically ill patients. Anesth. Analg., 2006, 102, p. 1809-1815.
Go to original source...
Go to PubMed...
- Müller-Werdan, U. et al. Septische Kardiomyopathie. Intensivmed, 2006, 43, p. 486-497.
Go to original source...
- Uchino, S. et al. Pulmonary artery catheter versus pulse contour analysis: a prospective epidemiological study. Crit. Care, 2006, p. R174.
Go to original source...
Go to PubMed...
- Maeder, M. Sepsis-Associated Myocardial Dysfunction: Diagnostic and Prognostic Impact of Cardiac Troponins and Natriuretic Peptides. Chest, 2006, 129, p. 1349-1366.
Go to original source...
Go to PubMed...
- Charpentier, J. et al. Brain natriuretic peptide: A marker of myocardial dysfunction and prognosis during severe sepsis. Crit. Care Med., 2004, 32, p. 660-665.
Go to original source...
Go to PubMed...
- Nielsen, L. N-terminal pro-brain natriuretic peptide for discriminating between cardiac and non-cardiac dyspnoea. European Journal of Heart Failure, 2004, 6, p. 63-70.
Go to original source...
Go to PubMed...
- Dellinger, R. P. et al. Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008. Intens. Care Med., 2008, 34, p. 17-60.
Go to original source...
- Bouch, D. C., Thompson, J. P. Severity scoring systems in the critically ill. Continuing Education in Anaesthesia, Crit. Care & Pain, 2008, 8, p. 181-185.
Go to original source...
- Minne, L., Abu-Hanna, A., Jonge, E. de Evaluation of SOFA-based models for predicting mortality in the ICU: A systematic review. Crit. Care, 2009, 12, p. R161.
Go to original source...
Go to PubMed...
- Higgins, T. L. et al. Assessing contemporary intensive care unit outcome: An updated Mortality Probability Admission Model (MPM0-III)*. Crit. Care Med., 2007, 35, p. 827-835.
Go to original source...
Go to PubMed...
- Khwannimit, B., Bhurayanontachai, R. The performance of customised APACHE II and SAPS II in predicting mortality of mixed critically ill patients in a Thai medical intensive care unit. Anaesth. Intensive Care, 2009, 37, p. 784-790.
Go to original source...
Go to PubMed...
- Galrinho, A. et al. Prognostic implications of tissue Doppler in patients with dilated cardiomyopathy. Rev. Port. Cardiol., 2006, 25, p. 781-793.
Go to PubMed...
- Landesberg, G. et al. Diastolic dysfunction and mortality in severe sepsis and septic shock. Eur. Heart J., 2012, 33, p. 895-903.
Go to original source...
Go to PubMed...
- Sturgess, D. J. et al. Prediction of hospital outcome in septic shock: a prospective comparison of tissue Doppler and cardiac biomarkers. Crit. Care, 2010, 14, p. R44.
Go to original source...
Go to PubMed...
- Sakka, S. et al. Prognostic value of extravascular lung water in critically ill patients. Chest, 2002, 122, p. 2080-2086.
Go to original source...
Go to PubMed...
- Phillips, C., Chesnutt, M., Smith, S. Extravascular lung water in sepsis-associated acute respiratory distress syndrome: indexing with predicted body weight improves correlation with severity of illness and survival. Crit. Care Med., 2008, 36, p. 69-73.
Go to original source...
Go to PubMed...
- Røsjø, H. et al. Circulating high sensitivity troponin T in severe sepsis and septic shock: distribution, associated factors, and relation to outcome. Intens. Care Med., 2011, 37, p. 77-85.
Go to original source...
Go to PubMed...
- Liu, D. et al. Prognostic value of plasma N-terminal pro-B-type natriuretic peptide in patients with severe sepsis and septic shock. Sichuan Da Xue Xue Bao Yi Xue Ban, 2011, 42, p. 369-373.
Go to PubMed...
- Park, B. et al. Prognostic utility of changes in N-terminal pro-brain natriuretic Peptide combined with sequential organ failure assessment scores in patients with acute lung injury/acute respiratory distress syndrome concomitant with septic shock. Shock, 2011, 36, p. 109-114.
Go to original source...
Go to PubMed...
- Cuthbertson, B. H. et al. B-Type natriuretic peptide and the prediction of outcome in patients admitted to intensive care. Anaesthesia, 2005, 60, p. 16-21.
Go to original source...
Go to PubMed...
- Park, M. S. et al. Prognostic utility of changes in N-terminal pro-brain natriuretic Peptide combined with sequential organ failure assessment scores in patients with acute lung injury/acute respiratory distress syndrome concomitant with septic shock. Shock Augusta Ga, 2010, 36, p. 109-114.
Go to original source...
Go to PubMed...
- Banach, M. et al. NT-proBNP levels correlate with organ failure in septic patients: a preliminary report. Postepy higieny i medycyny doswiadczalnej Online, 2006, 60, p. 632-636.
- Levy, M. M. et al. The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Intens. Care Med., 2010, 36, p. 222-231.
Go to original source...
Go to PubMed...
- Vaitsis, J. et al. Use of levosimendan in myocardial dysfunc-tion due to sepsis. Crit. Care, 2009, 13, p. P165.
Go to original source...
- Morelli, A. et al. Effects of levosimendan on systemic and regional hemodynamics in septic myocardial depression. Intensive Care Med., 2005, 31, p. 638-644.
Go to original source...
Go to PubMed...
- Tavener, S. A. et al. Immune cell Toll-like receptor 4 is re-quired for cardiac myocyte impairment during endotoxemia. Circ. Res., 2004, 95, p. 700-707.
Go to original source...
Go to PubMed...
- Leon, C. G. et al. Discovery and Development of Toll-Like Receptor 4 (TLR4) Antagonists: A New Paradigm for Treating Sepsis and Other Diseases. Pharm Res., 2008, 25, p. 1751-1761.
Go to original source...
Go to PubMed...
- Mokart, D. et al. N-terminal pro-brain natriuretic peptide as an early prognostic factor in cancer patients developing septic shock. Critical Care, 2007, 11, p. R37
Go to original source...
Go to PubMed...
- Van Kimmenade, R. R. et al. Renal clearance of B-type natriuretic peptide and amino terminal pro-B-type natriuretic peptide a mechanistic study in hypertensive subjects. J. Am. Coll. Cardiol., 2009, 53, p. 884-890.
Go to original source...
Go to PubMed...
- Raymond, I. et al. The influence of age, sex and other varia-bles on the plasma level of N-terminal pro brain natriuretic peptide in a large sample of the general population. Heart, 2003, 89, p. 745-775.
Go to original source...
Go to PubMed...
- Flierl, M. et al. Molecular events in the cardiomyopathy of sepsis. Molecular Medicine, 2008, 14, p. 327-336.
Go to original source...
Go to PubMed...
- Romero-Bermejo, F. J. et al. Sepsis-induced Cardiomyopathy. Current Cardiology Reviews, 2011, 7, p. 163-183.
Go to original source...
Go to PubMed...